Table 3 of
Kandpal, Mol Vis 2012; 18:1123-1146.
Table 3. Alterations in the levels of crystallin transcripts in diabetic retinopathy and the reversal of their levels by RAGE inhibitor and p38 MAPK inhibitor.
| Fold change* | Fold change* | Fold change* | ||
|---|---|---|---|---|
| Gene symbol | Gene name | D vs N | D + mRAGE-Fc vs N | D + PHA666859 vs N |
| Crybb2 | Crystallin, Beta B2 | 19.8 | 3.6 | 2.4 |
| Cryba1 | Crystallin, Beta A1 | 19.3 | 3.7 | 1.9 |
| Cryba4 | Crystallin, Beta A4 | 18.3 | 3.8 | 2.4 |
| Crygs | Crystallin, Gamma S | 18.2 | 3.9 | 2.5 |
| Cryaa | Crystallin, Alpha A | 17.9 | 3.5 | 2.4 |
| Cryba2 | Crystallin, Beta A2 | 16.4 | 3.4 | 2.1 |
| Crybb1 | Crystallin, Beta B1 | 15.1 | 3.9 | 2.8 |
| Crybb3 | Crystallin, Beta B3 | 9.2 | 3.2 | 2.5 |
| Cryab | Crystallin, Alpha B | 6.6 | 3.6 | 1.9 |
| Crygb | Crystallin, Gamma B | 4.5 | 3.2 | 2.2 |
| Crygd | Crystallin, Gamma D | 3.9 | 2.6 | 2.3 |
| Crygc | Crystallin, Gamma C | 2.4 | 1.7 | 1.6 |
| Crygn | Crystallin, Gamma N | 1.6 | 1.5 | 1.2 |